Source: International Congress 2014 – MS05 The sleepy OSA patient



Rating:

Share or cite this content

Citations should be made in the following way:
J. Verbraecken (Antwerp, Belgium). Case analysis of patients with OSAHS who have residual EDS after CPAP treatment. International Congress 2014 – MS05 The sleepy OSA patient

Member's Comments

No comment yet.

Related content which might interest you: Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Effects of CPAP treatment on 6MWD in OSAS and overlap syndrome patients Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 CPAP setting prediction in OSAS patients Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011 Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Predictors of compliance with CPAP in patients with OSA and metabolic syndrome Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Home automated CPAP titration is as effective as hospital CPAP titration in patients with obstructive sleep apnoea hypopnoea syndrome (OSAHS) Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004 The effect of CPAP in asthma patients with SAHS Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021 Residual sleepiness in patients with OSA on CPAP Source: Eur Respir J 2009; 34: 1209 Year: 2009 Insomnia, OSAS and CPAP treatment Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 Benefits to partners of nasal CPAP therapy given to patients with OSAS: a prospective analysis Source: Eur Respir J 2001; 18: Suppl. 33, 420s Year: 2001 Antiarrhythmic effect of CPAP and uvulopalatopharyngoplasty (UPPP) in patients with severe OSAS Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Health related quality of life after CPAP treatment in patients with obstructive sleep apnoea and patients with overlap syndrome Source: Eur Respir J 2003; 22: Suppl. 45, 468s Year: 2003 AutoCPAP in obstructive sleep apnea (OSA) patients with poor compliance to standard CPAP titration Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006 Implementation of continuous positive airway pressure treatment in patients with obstructive sleep apnoea-hypopnoea syndrome by the self titration method with auto-adjusting CPAP at home. Experience in the real life Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Evolution of treatment with CPAP over 21 months of follow-up in patients with sleep apnea hypopnea syndrome Source: Annual Congress 2011 - Epidemiology, diagnosis and treatment in obstructive sleep apnoea Year: 2011 Utility of a nurse-led visit program for patients with obstructive sleep apnea syndrome treated with CPAP Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Laryngeal obstruction in moderate and severe obstructive sleep apnea patients requested higher CPAP level during treatments Source: International Congress 2018 – Sleep and breathing control: phenotypes Year: 2018 Auto-CPAP for treatment of OSAS in severe obese patients Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005 CPAP and uvulopalatopharyngoplasty (UPPP) normalized pulmonary hypertension in patients with obstructive sleep apnea (OSAS) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007